ResearcherInsermActive in the last 2 years
Marie Müller
Matched on ORCID iD 0000-0001-6412-932X; OpenAlex author ID A5007017405. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 28
2019: 2 papers · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper
Papers 5
- Molecular analysis in pancreatic adenocarcinoma: a real-world study from high-volume French centres (CAPANCOBIO study). Co-author DOI 10.1016/j.esmogo.2025.100142↗
- Olaparib as maintenance therapy in non resectable pancreatic adenocarcinoma associated with homologous recombination deficiency profile: A French retrospective… Last author DOI 10.1016/j.ejca.2024.115051↗
- KRAS G12C inhibitors: also a new promising new targeted therapy in advanced pancreatic adenocarcinoma? Co-author DOI 10.21037/tcr-23-1629↗
- Familial pancreatic adenocarcinoma: A retrospective analysis of germline genetic testing in a French multicentre cohort. Co-author DOI 10.1111/cge.13629↗
- Appropriateness of pancreatic resection in high-risk individuals for familial pancreatic ductal adenocarcinoma: a patient-level meta-analysis and proposition o… First author DOI 10.1177/2050640618824910↗
Closest collaborators
The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- David Tougeron · 3 shared papers, 2023–2025 · strength 0.79
- Paper KRAS G12C inhibitors: also a new promising new targeted therapy in advanced pancreatic adenocarcinoma? DOI 10.21037/tcr-23-1629↗
- Paper Molecular analysis in pancreatic adenocarcinoma: a real-world study from high-volume French centres (CAPANCOBIO study). DOI 10.1016/j.esmogo.2025.100142↗
- Paper Olaparib as maintenance therapy in non resectable pancreatic adenocarcinoma associated with homologous recombination de… DOI 10.1016/j.ejca.2024.115051↗
- Olivier Bouché · 2 shared papers, 2024–2025 · strength 0.40
- Paper Molecular analysis in pancreatic adenocarcinoma: a real-world study from high-volume French centres (CAPANCOBIO study). DOI 10.1016/j.esmogo.2025.100142↗
- Paper Olaparib as maintenance therapy in non resectable pancreatic adenocarcinoma associated with homologous recombination de… DOI 10.1016/j.ejca.2024.115051↗
- Louis de Mestier · 3 shared papers, 2019–2024 · strength 0.32
- Paper Olaparib as maintenance therapy in non resectable pancreatic adenocarcinoma associated with homologous recombination de… DOI 10.1016/j.ejca.2024.115051↗
- Paper Appropriateness of pancreatic resection in high-risk individuals for familial pancreatic ductal adenocarcinoma: a patie… DOI 10.1177/2050640618824910↗
- Paper Familial pancreatic adenocarcinoma: A retrospective analysis of germline genetic testing in a French multicentre cohort. DOI 10.1111/cge.13629↗
- Gaël S. Roth · 1 shared paper, 2025 · strength 0.25
- Mathias Brügel · 1 shared paper, 2025 · strength 0.25
- Camille Evrard · 1 shared paper, 2025 · strength 0.25
- Nicolas Williet · 1 shared paper, 2025 · strength 0.25
- Vinciane Rebours · 2 shared papers, 2019 · strength 0.16
- Paper Appropriateness of pancreatic resection in high-risk individuals for familial pancreatic ductal adenocarcinoma: a patie… DOI 10.1177/2050640618824910↗
- Paper Familial pancreatic adenocarcinoma: A retrospective analysis of germline genetic testing in a French multicentre cohort. DOI 10.1111/cge.13629↗
- Jerome F. Cros · 2 shared papers, 2019 · strength 0.16
- Paper Appropriateness of pancreatic resection in high-risk individuals for familial pancreatic ductal adenocarcinoma: a patie… DOI 10.1177/2050640618824910↗
- Paper Familial pancreatic adenocarcinoma: A retrospective analysis of germline genetic testing in a French multicentre cohort. DOI 10.1111/cge.13629↗
- Pascal R. Hammel · 2 shared papers, 2019 · strength 0.16
- Paper Appropriateness of pancreatic resection in high-risk individuals for familial pancreatic ductal adenocarcinoma: a patie… DOI 10.1177/2050640618824910↗
- Paper Familial pancreatic adenocarcinoma: A retrospective analysis of germline genetic testing in a French multicentre cohort. DOI 10.1111/cge.13629↗
- Jeannie M'Baloula · 1 shared paper, 2024 · strength 0.16
- Anna Pellat · 1 shared paper, 2024 · strength 0.16
- Jean‐Frédéric Blanc · 1 shared paper, 2024 · strength 0.16
- Anthony Turpin · 1 shared paper, 2024 · strength 0.16
- Solène Doat · 1 shared paper, 2024 · strength 0.16
- Isabelle Trouilloud · 1 shared paper, 2024 · strength 0.16
- Anne‐Laure Védié · 1 shared paper, 2024 · strength 0.16
- Alice Boilève · 1 shared paper, 2024 · strength 0.16
- Julien Taı̈eb · 1 shared paper, 2024 · strength 0.16
- François‐Xavier Caroli‐Bosc · 1 shared paper, 2024 · strength 0.16
- Déwi Vernerey · 1 shared paper, 2019 · strength 0.09
- Frédérique Maire · 1 shared paper, 2019 · strength 0.09
- Safi Dokmak · 1 shared paper, 2019 · strength 0.09
- Marie‐Pierre Vullierme · 1 shared paper, 2019 · strength 0.09
- Alain Sauvanet · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.